Caribou Biosciences (CRBU) Receivables - Net (2020 - 2026)
Caribou Biosciences (CRBU) recorded Receivables - Net of $203,000 in Q2 2026, up 185.9% from $71,000 a year earlier but down 10.6% from the prior quarter.
Powered by 
Analysis
Caribou Biosciences (CRBU) Receivables - Net (2020 - 2026) Analysis & Trends
At the end of FY2025, Caribou Biosciences reported Receivables - Net of $69,000, down 74.0% from FY2024.
- Annual Receivables - Net has a five-year compound annual growth rate of -14.4% (FY2020 to FY2025).
- Across earlier years, Receivables - Net came in at $265,000 in FY2024 (+79.1%), $148,000 in FY2023 (-26.7%), $202,000 in FY2022 (-82.5%) and $1.15 million in FY2021 (+668.7%).
- Quarterly Receivables - Net has ranged from $69,000 in Q4 2025 to $1.53 million in Q1 2023 over the past five years.
- On a year-over-year basis, Receivables - Net rose in four of the last eight quarters, with growth averaging 17.4%.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 668.7% in Q4 2021, against a decline of 90.4% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $227,000 (Q1 2026), $69,000 (Q4 2025) and $242,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Caribou Biosciences | 56.06 Mn | -460.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 203,000.00 |
| Mar 31, 2026 | 227,000.00 |
| Dec 31, 2025 | 69,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | 265,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 215,000.00 |
| Mar 31, 2024 | 917,000.00 |
| Dec 31, 2023 | 148,000.00 |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 766,000.00 |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 202,000.00 |
| Sep 30, 2022 | 397,000.00 |
| Jun 30, 2022 | 524,000.00 |
| Mar 31, 2022 | 374,000.00 |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | 578,000.00 |
API Access
Caribou Biosciences Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();